{"disease":{"id":"prevention-of-eclampsia-in-patients-with-preeclampsia","name":"prevention of eclampsia in patients with preeclampsia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[{"drug_id":"magnesium-sulfate-in-dextrose-5-in-plastic-container","guideline_body":"FDA label","recommendation":"Magnesium Sulfate in 5% Dextrose Injection is indicated for the prevention of eclampsia in patients with preeclampsia.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null},{"drug_id":"magnesium-sulfate-in-dextrose-5-in-plastic-container","guideline_body":"FDA label","recommendation":"Magnesium Sulfate in 5% Dextrose Injection is indicated for the treatment of seizures in patients with eclampsia.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null},{"drug_id":"magnesium-sulfate-in-dextrose-5-in-plastic-container","guideline_body":"FDA label","recommendation":"Magnesium Sulfate in 5% Dextrose Injection is indicated for the prevention of recurrent seizures in patients with eclampsia.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null}],"source":"Drug Landscape verified database"}